- RTX maintains its full-year adjusted sales forecast between $83 billion and $84 billion, slightly below the expected $84.21 billion.
- The company forecasts adjusted earnings per share (EPS) to be between $6 and $6.15, close to the estimated $6.11.
- Expected free cash flow is projected to range from $7 billion to $7.5 billion, with an estimate of $7.15 billion.
- In the first quarter, RTX reported an adjusted EPS of $1.47, exceeding the estimated $1.38.
- First-quarter adjusted sales reached $20.31 billion, surpassing the forecasted $19.84 billion.
- Sales for the same period were reported as $20.31 billion.
- Collins Aerospace Systems achieved sales of $7.22 billion, higher than the expected $6.95 billion.
- Pratt & Whitney reported sales of $7.37 billion, exceeding the estimated $6.94 billion.
- Raytheon’s sales were $6.34 billion, slightly below the projected $6.52 billion.
- Free cash flow for the first quarter was $792 million, significantly less than the anticipated $10.3 million.
- The forecast does not take into account the effects of new U.S. and non-U.S. tariffs.
- The company’s first-quarter backlog stands at $217 billion, with $125 billion in commercial and $92 billion in defense orders.
Raytheon Technologies on Smartkarma
Analyst coverage of Raytheon Technologies on Smartkarma highlights positive sentiments regarding the company’s financial performance and market position. Baptista Research‘s recent reports delve into key drivers propelling Raytheon’s success, with a focus on its impressive fourth-quarter results in 2024. The company achieved significant revenue growth, posting adjusted sales of $80.8 billion and a 13% increase in earnings per share, signaling a robust performance in commercial and defense sectors.
Furthermore, Baptista Research assesses the potential revenue impact of global defense spending and military modernization on RTX Corporation. The analysis emphasizes the company’s strong performance in various segments, including commercial airlines and defense, showcasing solid organic growth and improved segment margins. With a thorough evaluation of market factors and a focus on future valuation using Discounted Cash Flow methodology, analysts project a positive outlook for Raytheon Technologies amidst evolving industry dynamics.
A look at Raytheon Technologies Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Raytheon Technologies Corporation, known for its innovative solutions in aircraft manufacturing, has received positive Smart Scores across various factors. With strong momentum and growth prospects, the company is positioned well for the long term. The high momentum score reflects the market’s confidence in Raytheon Technologies’ future performance. This is complemented by a solid growth score, indicating potential for expansion and development in the industry.
Additionally, Raytheon Technologies demonstrates resilience, a key factor for success in the ever-evolving market landscape. While the company has room for improvement in the value and dividend categories based on the scores, its overall outlook remains optimistic. Leveraging its technological offerings and engineering expertise, Raytheon Technologies is well-equipped to navigate challenges and capitalize on opportunities in the aircraft manufacturing sector.
Summary: Raytheon Technologies Corporation operates as an aircraft manufacturing company, specializing in delivering innovative solutions through a range of products such as aero structures, avionics, aircraft engines, radars, and more, supported by advanced technology and engineering teams.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
